Benjamin N. Greener

Deaminase-Independent Inhibition of Parvoviruses by the APOBEC3A Cytidine Deaminase

Iñigo Narvaiza, Daniel C. Linfesty, Benjamin N. Greener et al. · PLoS Pathogens · 2009 · 135 citations · Full text

Viral Replication, Molecular Virology, Deaminase-independent Inhibition +15

Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial

Yoshiaki Oda, Yuji Kumagai, Manabu Kanai et al. · The Lancet Infectious Diseases · 2023 · 99 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +8

Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials

Nhân Thị Hồ, Steven G. Hughes, Van Thanh Ta et al. · Nature Communications · 2024 · 67 citations · Full text

Dolutegravir Pharmacokinetics in the Genital Tract and Colorectum of HIV-Negative Men After Single and Multiple Dosing

Benjamin N. Greener, Kristine B. Patterson, Heather M. A. Prince et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2013 · 60 citations · Full text

Single and Multiple Dose Pharmacokinetics of Dolutegravir in the Genital Tract of HIV-Negative Women

Jessica Adams, Kristine B. Patterson, Heather M. A. Prince et al. · Antiviral Therapy · 2013 · 37 citations